(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNIZYME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

IMMUNIZYME

ST13

US500000086321918

Class

5

Filing

86321918

Registration

4681672

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

06/27/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

06/26/2014

Registration date

02/03/2015

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/02/2020

Last transaction

06/27/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/30/2014

First use in commerce

04/30/2014

Drawing code

4

Owner type

03

Owner location

Omaha, NE

Examiner

CUCCIAS,MATTHEW JAMES

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AMERICAN LABORATORIES, INC.

Representatives

Clint D. Cadwallader McGrath North Mullin & Kratz, PC LLO

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

DIETARY AND NUTRITIONAL SUPPLEMENTS CONTAINING HYDROLYZED GLYCOPROTEIN

Publications

History of USPTO decisions and trademark events.

32 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/03/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/03/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/03/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/03/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

07/15/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/03/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/08/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

08/03/2022

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

05/03/2021

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

05/03/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/03/2021

ES8R

TEAS SECTION 8 RECEIVED

02/03/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/12/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/12/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/12/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/12/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/12/2020

TMBN

TTAB RELEASE CASE TO TRADEMARKS

06/02/2020

CANT

CANCELLATION TERMINATED NO. 999999

06/02/2020

CAND

CANCELLATION DENIED NO. 999999

06/02/2020

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/27/2020

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/01/2020

PETC

CANCELLATION INSTITUTED NO. 999999

03/05/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/03/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

02/03/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/18/2014

PUBO

PUBLISHED FOR OPPOSITION

11/18/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/29/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/14/2014

DOCK

ASSIGNED TO EXAMINER

10/03/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/02/2014

NWAP

NEW APPLICATION ENTERED

06/30/2014

Continuous trademark protection

Get notified about every new filing that threatens IMMUNIZYME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.